title: New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome.
authors.affiliation: Department of Medicine, University of Utah Health Science Center, Salt Lake City, Utah.
authors.forename: Khine
authors.initials: K
authors.lastname: Win
authors.forename: George M
authors.initials: GM
authors.lastname: Rodgers
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D000991:Antithrombins / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage*; D000069604:Dabigatran; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000008:administration & dosage*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage*; D054556:Venous Thromboembolism / Q000517:prevention & control*; D015091:beta-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D009025:Morpholines; D013876:Thiophenes; D015091:beta-Alanine; D000069552:Rivaroxaban; D000069604:Dabigatran